Brant Point Investment Management’s Idexx Laboratories IDXX Stock Holding History

Brant Point Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.7M	Sell	8,931 -500	-5%	-$280K	0.58%	48
2026 Q1	$5.3M	Sell	9,431 -453	-5%	-$290K	0.68%	34
2025 Q4	$6.69M	Hold	9,884	–	–	0.81%	26
2025 Q3	$6.31M	Sell	9,884 -1,392	-12%	-$845K	0.68%	31
2025 Q2	$6.05M	Sell	11,276 -1,072	-9%	-$513K	0.63%	30
2025 Q1	$5.19M	Buy	12,348 +2,348	+23%	+$1.02M	0.62%	38
2024 Q4	$4.13M	Buy	+10,000	New	+$4.39M	0.52%	59

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Brant Point Investment Management's IDXX Position: Q2 2026 in Review

Brant Point Investment Management reduced its Idexx Laboratories (IDXX) stake by 5.3% in Q2 2026, selling an estimated $280K and leaving 8,931 shares worth $4.7M. The position accounts for 0.58% of the portfolio, ranked #48.

Brant Point Investment Management first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.69M in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Brant Point Investment Management held 8,931 shares of Idexx Laboratories worth $4.7M as of Q2 2026.
Brant Point Investment Management sold 500 Idexx Laboratories shares in Q2 2026, an estimated $280K.
Idexx Laboratories made up 0.58% of Brant Point Investment Management's portfolio in Q2 2026, its #48 holding.
Brant Point Investment Management first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
Brant Point Investment Management's Idexx Laboratories position peaked at $6.69M in Q4 2025.
1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Brant Point Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.